Evidence-Based Medicine
Erasmus MC: University Medical Center Rotterdam

Roobol-Bouts, M., Carlsson, S., & Hugosson, J. (2011). Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related or all-cause mortality but results likely due to heterogeneity - The two highest quality studies identified do find prostate cancer-related mortality reductions. Evidence-Based Medicine (Vol. 16, pp. 20–21). doi:10.1136/ebm1165